NEW: PepMix Peptide Pools for current SARS-CoV-2 variants
Published on 16/01/2023
The Covid-19 disease has reached an endemic status thus suggesting a need to stay current with vaccination plans and therapy development. More variants have emerged and JPT remains dedicated to provide researchers with up-to-date tools for immune monitoring and immune response profiling covering the SARS-CoV-2 virus’ spike glycoprotein and respective RBD.
Now available PepMix Peptide Pools:
Besides our many other PepMix Peptide Pools or PepStar Peptide Microarrays covering SARS-CoV-2 antigens, we also offer PepMix Pan Select which combine immunodominant epitopes, or PepMix Collections which include many important PepMix’ of important antigens at a lower total cost.
Also, have a look at our dedicated SARS-CoV-2 page with a plethora of information on all the variants and relevant mutations. If you have any questions, or a tailored Custom Peptide Synthesis request please reach out to our experienced customer support team.